Cheikh Njie, MD
Assistant Professor
Medicine
School of Medicine

Awards

Show all (4) Hide

• Sinker Miller Scholar, UCSF, 2016
• Research Initiative Scientific Enhancement Scholar, San Francisco State University
• Phi Beta Kappa, San Francisco State University
• Bernard Osher Scholar, UCSF

Education & Training

Show all (4) Hide

• Fellowship in Gastroenterology and Hepatology University of California, San Francisco 06/2024
• Residency in Internal Medicine Brigham and Women's Hospital 06/2021
• M.D. School of Medicine University of California, San Francisco 05/2014
• B.S. Biochemistry San Francisco State University 06/2013

Interests

Show all (6) Hide

• GERD
• Esophageal disorders
• Motility
• Achalasia
• Eosinophilic Esophagitis
• Colon cancer prevention

Publications (5)

Top publication keywords:
Treatment FailureLogistic ModelsMassachusettsCoronavirus InfectionsNew YorkRetrospective StudiesCritical IllnessRisk AssessmentCrohn DiseasePneumonia, ViralHospitalizationLiver CirrhosisAdrenal Cortex HormonesRemission InductionUstekinumab

• Identification of gaps in the delivery of high-quality care of patients with eosinophilic esophagitis.
  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 2024 Njie C, Richman C, Rebhun J, Achalu S, Kamal AN, Otaki F, Leiman DA, Kathpalia P
• How Do Presenting Symptoms and Outcomes Differ by Race/Ethnicity Among Hospitalized Patients With Coronavirus Disease 2019 Infection? Experience in Massachusetts.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 McCarty TR, Hathorn KE, Redd WD, Rodriguez NJ, Zhou JC, Bazarbashi AN, Njie C, Wong D, Trinh QD, Shen L, Stone VE, Chan WW
• Predictors of Ustekinumab Failure in Crohn's Disease After Dose Intensification.
  Inflammatory bowel diseases 2021 Dalal RS, Njie C, Marcus J, Gupta S, Allegretti JR
• Development and external validation of a prediction risk model for short-term mortality among hospitalized U.S. COVID-19 patients: A proposal for the COVID-AID risk tool.
  PloS one 2020 Hajifathalian K, Sharaiha RZ, Kumar S, Krisko T, Skaf D, Ang B, Redd WD, Zhou JC, Hathorn KE, McCarty TR, Bazarbashi AN, Njie C, Wong D, Shen L, Sholle E, Cohen DE, Brown RS, Chan WW, Fortune BE
• Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicentre United States experience.
  Liver international : official journal of the International Association for the Study of the Liver 2020 Hashemi N, Viveiros K, Redd WD, Zhou JC, McCarty TR, Bazarbashi AN, Hathorn KE, Wong D, Njie C, Shen L, Chan WW